iodoacetamide has been researched along with Anemia, Sickle Cell in 2 studies
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, T | 1 |
| Ohnishi, ST | 1 |
| Costa, FF | 1 |
| Zago, MA | 1 |
| Bottura, C | 1 |
2 other studies available for iodoacetamide and Anemia, Sickle Cell
| Article | Year |
|---|---|
Effects of sulfhydryl reagents on the anti-sickling activity of some membrane-interacting compounds.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Chlorpromazine; Erythrocytes; Ethylmaleimide; Human | 1983 |
Effects of piracetam and iodoacetamide on erythrocyte sickling.
Topics: Anemia, Sickle Cell; Animals; Antisickling Agents; Erythrocyte Aging; Erythrocytes, Abnormal; Humans | 1979 |